It was part of a 3m sale of two drugs stocks by the UK's biggest quoted venture investor, as MDY snapped up 1.2% of ProStrakan at 61.5p a share, Thursday's closing price. The shares, which doubled to top 100p between March and August last year, firmed ...


Recent comments
6 years 18 weeks ago
15 years 35 weeks ago
15 years 36 weeks ago
15 years 36 weeks ago
16 years 1 week ago
16 years 1 week ago
16 years 8 weeks ago
16 years 26 weeks ago
17 years 8 weeks ago
17 years 8 weeks ago